
The publishers claim that this newly published Journal aims at scientists and health professionals interested in molecular aspects of the development, diagnosis and treatment of cancer and highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational research.
We agree with the publishers when they say that a main feature of the Journal is to provide an international debate Forum where researchers, health care providers, patient advocates and other cancer stakeholders can raise awareness to issues of broad interest.
Julio E. Celis, who is involved with Danish Cancer Society, Copenhagen, Denmark, is the Editor-in-chief.
On behalf of the Federation of European Biomedical Societies, Elsevier has published this journal.
Molecular Oncology
Free access to selected content, news items related to Molecular Oncology, free special issues and other pertinent journal information can be found at a dedicated Molecular Oncology website
Bibliographic Information
ISSN: 1574-7891
Topics in Molecular Oncology include:
Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response.
Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems.
Biomarkers: diagnosis, prognosis, stratification and efficacy.
Cancer genetics, epigenetics, and genomic instability.
Minimal residual disease, pre-malignant lesions.
Cancer micro-environment.
Molecular pathology.
Tumour immunology.
Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance, and individualised treatment). Chemotherapy, radiotherapy and surgery.
Clinical pharmacology.
Clinical trials, integration of basic science into cancer clinical trials.
Epidemiology and prevention.
Infrastructures (biobanks, databases, genomic resources)
If you find it nice, do comment.
All the best